The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer. The ...

UroGen Pharma received Food and Drug Administration approval for bladder cancer drug Zusduri, previously known as UGN-102. The company expects the drug will be available on or about July 1. It was ...

The U.S. Food and Drug Administration said on Wednesday it has approved Nuvation Bio's drug for patients with a rare and ...

The FDA approved taletrectinib for ROS1-positive NSCLC. The agent shows efficacy for both new and pretreated cases, including ...

The drug, Ibtrozi, will now vie for market share in an indication where multiple large pharmaceutical companies have already ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of ...

Oct. 24, 2024 – The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer. Marketed under the brand name Vyloy, the drug is to ...

Hugely promising cancer drug dostarlimab is one step closer to ... during which around 30-40% of requests have been approved. Dostarlimab has been watched closely by oncologists since its trial ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for adult and pediatric patients 12 years and older with locally advanced ...

The maker of an at-home cervical cancer screening test said Friday it has won approval from the Food and Drug Administration, giving patients an alternative to in-clinic pap smears. The screening ...

Verastem Oncology said the Food and Drug ... approved the combination of avutometinib capsules and defactinib tablets for certain patients with KRAS-mutated recurrent low-grade serous ovarian cancer.